Your browser is no longer supported. Please, upgrade your browser.
SBOT Stellar Biotechnologies, Inc. monthly Stock Chart
SBOT [NASD]
Stellar Biotechnologies, Inc.
Index- P/E- EPS (ttm)-3.49 Insider Own0.60% Shs Outstand4.75M Perf Week0.00%
Market Cap8.36M Forward P/E- EPS next Y- Insider Trans- Shs Float4.13M Perf Month4.14%
Income-5.20M PEG- EPS next Q- Inst Own13.10% Short Float11.50% Perf Quarter-66.02%
Sales0.10M P/S83.60 EPS this Y13.70% Inst Trans- Short Ratio0.35 Perf Half Y-73.25%
Book/sh3.15 P/B0.56 EPS next Y- ROA-72.50% Target Price2.00 Perf Year-81.91%
Cash/sh0.80 P/C2.20 EPS next 5Y- ROE-77.70% 52W Range1.65 - 10.85 Perf YTD-68.96%
Dividend- P/FCF- EPS past 5Y16.20% ROI-70.60% 52W High-83.68% Beta0.29
Dividend %- Quick Ratio6.90 Sales past 5Y-4.40% Gross Margin- 52W Low7.31% ATR0.13
Employees23 Current Ratio7.20 Sales Q/Q0.00% Oper. Margin- RSI (14)44.44 Volatility3.41% 8.50%
OptionableNo Debt/Eq0.00 EPS Q/Q-18.10% Profit Margin- Rel Volume0.03 Prev Close1.76
ShortableYes LT Debt/Eq0.00 EarningsAug 08 AMC Payout- Avg Volume1.36M Price1.77
Recom2.00 SMA20-2.67% SMA50-12.26% SMA200-66.90% Volume29,423 Change0.60%
Dec-02-16Reiterated Maxim Group Buy $7 → $4
Aug-01-16Reiterated Maxim Group Buy $17 → $7
Jul-10-18 09:30AM  SBOT: Neovacs Announces Ph2 Lupus Results, Will Enable Us To Move Into Ph3 Zacks Small Cap Research
Jul-05-18 07:30AM  Stellar Issues Statement on Favorable Clinical Study Results PR Newswire
Jun-22-18 08:10AM  Todays Research Reports on Stocks to Watch: Heron Therapeutics and Stellar Biotechnologies ACCESSWIRE -11.96%
Jun-21-18 08:54AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +26.67%
07:30AM  Stellar Reports Positive Research Results from KLH Glycosylation Study PR Newswire
Jun-20-18 07:50AM  Stock Performance Review on Sesen Bio and Three Other Biotech ACCESSWIRE
Jun-04-18 11:54AM  How Has Stellar Biotechnologies Incs (NASDAQ:SBOT) Performed Against The Industry? Simply Wall St.
May-25-18 08:10AM  Todays Research Reports on Stocks to Watch: Recro Pharma and Stellar Biotechnologies ACCESSWIRE -7.73%
May-24-18 03:15PM  Stellar Biotechnologies Announces Exercise of Warrants Resulting in Cash Proceeds of $3 Million PR Newswire
07:30AM  Stellar Achieves Robust Viral Clearance for Manufacturing Process PR Newswire
May-15-18 04:05PM  Stellar Biotechnologies Announces Closing of $5.5 Million Public Offering PR Newswire
May-11-18 09:20AM  SBOT: Q2 2018 Financial Results/Update: Neovacs reiterates Ph2 Lupus data expected in June Zacks Small Cap Research -41.24%
08:58AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
06:00AM  Stellar Biotechnologies Announces Pricing of $5.5 Million Public Offering PR Newswire
May-07-18 08:30AM  Stellar Biotechnologies Reports Second Quarter Financial Results PR Newswire +8.33%
Apr-27-18 04:30PM  Stellar Biotechnologies Announces One-for-Seven Reverse Split PR Newswire
Mar-29-18 08:45AM  Stellar Biotech Begins Scale-Up and Expansion Project at Port Facility PR Newswire +6.48%
Feb-27-18 09:00AM  Stellar Biotechnologies Appoints Bioprocess Expert to Lead Manufacturing PR Newswire
Feb-14-18 11:00AM  SBOT: Potential Key Milestone Upcoming As Neovacs Confirms Ph2 Lupus Data Expected June 2018 Zacks Small Cap Research
Feb-07-18 04:05PM  Stellar Biotechnologies Reports First Quarter 2018 Financial Results PR Newswire
Jan-25-18 08:30AM  Stellar Biotechnologies Appoints Pharma Licensing Expert to Board of Directors PR Newswire
Dec-27-17 08:38AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q4, 2017 By the Numbers : December 27, 2017 Capital Cube
Dec-21-17 07:20AM  Wired News Asterias Reports Enrollment and Dosing of Last Subject in SciStar Trial In Treatment of Severe Spinal Cord Injury ACCESSWIRE
Dec-06-17 11:00AM  SBOT: Important Clinical Program Related Milestones Upcoming Zacks Small Cap Research
Dec-05-17 11:00AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: 2017 By the Numbers : December 5, 2017 Capital Cube
Dec-01-17 08:00AM  Stellar Biotechnologies Reports Fiscal Year 2017 Financial Results PR Newswire +6.17%
Nov-30-17 12:15PM  SBOT: Neovacs' Ph IIb Lupus Study Could Read-Out 1H 2018 Zacks Small Cap Research
Nov-29-17 08:30AM  Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference PR Newswire
Oct-17-17 09:11PM  Should You Buy Stellar Biotechnologies Inc (SBOT) Now? Simply Wall St.
Sep-05-17 09:00AM  SBOT: Neovacs Ph 2 Lupus Study Completes Enrollment. Read-Out Q2 2018 Zacks Small Cap Research
Aug-24-17 11:40AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q3, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-09-17 04:05PM  Stellar Biotechnologies Reports Third Quarter 2017 Financial Results PR Newswire
Jun-07-17 08:30AM  Stellar Biotechnologies Expands Operations Team PR Newswire
Jun-02-17 10:02AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q2, 2017 By the Numbers : June 2, 2017 Capital Cube
May-31-17 08:15AM  Stellar Biotechnologies to Present at Marcum Investor Conference PR Newswire
May-26-17 09:00AM  SBOT: Clinical Trial Progression Remains Key Metric Zacks Small Cap Research
May-09-17 04:15PM  Stellar Biotechnologies Reports Second Quarter 2017 Financial Results PR Newswire
Mar-29-17 06:03AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
Mar-20-17 11:58AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017 Capital Cube
11:58AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017
Mar-14-17 08:00AM  Why Valeant, Tesla, Citrix Systems, Ruby Tuesday, and Stellar Biotechnologies Are in the Spotlight Insider Monkey
08:00AM  Why Valeant, Tesla, Citrix Systems, Ruby Tuesday, and Stellar Biotechnologies Are in the Spotlight at Insider Monkey
Mar-13-17 05:02PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, Finan
04:55PM  Stellar Biotechnologies and Matrivax Sign Agreement to Transfer Vaccine Technology PR Newswire
Mar-06-17 08:45AM  The Life Sciences Report Examines Stellar Biotechnologies (SBOT:NASDAQ) Inking Multiyear KLH Supply Agreement with Amaran Biotechnology; Stellar Up 27% on News Marketwired
Mar-02-17 09:00AM  The Life Sciences Report Examines How Stellar Biotechnologies Could Rise with KLH Vaccine Trial Success Marketwired +8.12%
Mar-01-17 07:30AM  Amaran Biotechnology Selects Stellar KLH for Cancer Vaccines PR Newswire
Feb-10-17 01:04PM  STELLAR BIOTECHNOLOGIES, INC. Financials -7.22%
Feb-09-17 08:15AM  SBOT: Q1 Light On Revenue But Clinical Trial Progression Suggests Growth Ahead Zacks Small Cap Research +5.88%
08:15AM  Q1 Light On Revenue But Clinical Trial Progression Suggests Growth Ahead
Feb-07-17 06:05AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Feb-06-17 07:15PM  Stellar Biotechnologies Reports First Quarter 2017 Financial Results PR Newswire
05:27PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 10-Q, Quarterly Report
07:30AM  Stellar Biotechnologies Congratulates Partner's Decision to Extend Drug Development for Diabetes PR Newswire
Jan-11-17 07:30AM  Stellar Biotechnologies Advances Strategic Plan to Secure Key Production Region Marketwired
Jan-04-17 07:30AM  Stellar Biotechnologies to Present at Biotech Showcase Conference Marketwired
Dec-19-16 03:00PM  SBOT: 2016 A Solid Year, Both Financially and Operationally
08:24AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: 2016 By the Numbers : December 19, 2016
Dec-14-16 04:22PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  Stellar Biotechnologies Reports Fiscal Year 2016 Financial Results Marketwired
Dec-12-16 07:45AM  Stellar Biotechnologies Announces Fiscal Year 2016 Corporate Update Conference Call Marketwired
Dec-09-16 08:01AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial
07:45AM  Stellar Biotechnologies Appoints Pharma and Capital Markets Experts to Board of Directors Marketwired
Dec-07-16 04:09PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Dec-01-16 07:45AM  Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference Marketwired +12.63%
Oct-24-16 09:28AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
07:30AM  Stellar Board Member and Pharma Expert to Join Executive Team Marketwired
Oct-05-16 08:30AM  Stellar Appoints Investor Relations Executive to Management Team to Support Its Continuing Scale-Up Marketwired
Oct-04-16 07:00AM  VistaGen Therapeutics Appoints Mark A. McPartland Vice President of Corporate Development and Investor Relations PR Newswire -9.02%
Sep-27-16 04:31PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Sep-21-16 08:30AM  Stellar Biotechnologies to Present at International Aquaculture Symposium Marketwired -5.59%
Sep-06-16 08:30AM  Stellar Biotechnologies to Present at the 18th Rodman & Renshaw 2016 Annual Global Investment Conference Marketwired
Aug-11-16 11:29AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q3, 2016 By the Numbers : August 11, 2016
11:00AM  SBOT Preparing To Scale In Anticipation of Growing Demand
Aug-09-16 08:02AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition
08:00AM  Stellar Biotechnologies Reports Third Quarter 2016 Financial Results and Operational Highlights Marketwired
Aug-04-16 08:30AM  Stellar Biotechnologies Announces Third Quarter 2016 Corporate Update Conference Call Marketwired
Jul-19-16 04:14PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events
08:00AM  Stellar Biotechnologies and Neovacs Announce Formation of New Company Neostell S.A.S. in France Marketwired
02:15AM  Neovacs and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture to Manufacture Kinoids GlobeNewswire
Jul-07-16 06:02AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events
Jul-06-16 12:00PM  Stellar Biotechnologies Announces Closing of Registered Direct Offering Marketwired
Jun-30-16 12:42PM  Heres Why Traders Are Buzzing Around Lions Gate, Stellar Biotechnologies, and Three Other Stocks at Insider Monkey
09:23AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq
08:45AM  Stellar Biotechnologies Announces Pricing of $6.75 Million Registered Direct Offering Marketwired
Jun-23-16 09:00AM  Maxim's Jason McCarthy Interviewed by The Life Sciences Report Marketwired
Jun-02-16 08:00AM  Stellar Biotechnologies to Present at LD Micro Invitational Conference Marketwired
May-25-16 11:29AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events
09:00AM  Stellar Biotechnologies Named as a 2016 California Small Business of the Year Marketwired
May-23-16 11:17AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events
08:30AM  Stellar Biotechnologies Appoints Michael L. Klein, Ph.D. as Vice President of Chemistry, Manufacturing and Controls (CMC) Marketwired
May-17-16 04:33PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial
May-16-16 10:30AM  SBOT: JV Consummated, Neovacs' Lupus Candidate Closer to Commercialization
May-12-16 11:32AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q2, 2016 By the Numbers
02:15AM  Neovacs and Stellar Biotechnologies sign joint venture agreement to create Neostell SAS GlobeNewswire
May-11-16 10:02AM  Stellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines With Stellar KLH(TM) Marketwired
May-10-16 06:06AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
May-09-16 06:08PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 10-Q, Quarterly Report
05:18PM  Stellar Biotechnologies Reports Second Quarter 2016 Financial Results and Operational Highlights Marketwired
May-03-16 08:30AM  Stellar Biotechnologies Announces Second Quarter 2016 Corporate Update Conference Call Marketwired
Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market. It provides its KLH protein under the Stellar KLH brand. The company's products include Stellar KLH protein in various grades, formulations, custom configurations, and fill finishes for drug development and research applications, as well as KLH-based in vitro diagnostic kits for research and preclinical use. Its customers and partners comprise biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers. Stellar Biotechnologies, Inc. is based in Port Hueneme, California.